DMACDiaMedica Therapeutics Inc.

$8.01+17% 1Y

Is it safe?

Watch

Caution warranted: heavy debt (CCC) and big price swings.

2 to watch, 4 without data
Credit gradeCCCderived · Jun 30, 2026

Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.

Drawdown risk68% volderived · Oct 8, 2026

Large price swings, high volatility. Worst drawdown -92% · now 15% below its 52-week high.

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can DMAC take a bad year?

The deepest fall in DMAC's price history on file is −92%; it is 15% below its high today.

−92%

Worst drawdown on file · −15% today

Cash runway
1.4 years

Cash runway · burning $7.9M a quarter at the current rate

Annualised volatility
68%

Annualised volatility · three times the market's own swing

Details›
Cash and short-term investments
$44M
EBITDA, trailing twelve months
−$39M
Operating profit, trailing twelve months
−$39M
Annualised volatilitytwo years of daily moves
68%
Worst drawdown on file
−92%
Below its 52-week high
15%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.